Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH banner announces transition updates and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-22T13:51:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer's displayed revision advances from v3.7.1 to v3.7.2 on the study record's 403 Forbidden page.
    Difference
    0.3%
    Check dated 2026-10-15T13:11:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-08T13:27:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a simple header and a Home link, indicating restricted access rather than active content. The previously visible study details have been removed, leaving an error state.
    Difference
    19%
    Check dated 2026-09-24T18:07:24.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added and Revision: v3.6.6 was removed, indicating a new page version in the site's revision history. This update does not alter page content or user-facing features.
    Difference
    0.0%
    Check dated 2026-09-17T18:53:43.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a background update to the site or content-management system.
    Difference
    0.0%
    Check dated 2026-09-03T18:21:18.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.